Filed: 11/14/2025ACC: 0001104659-25-111909
📋 What this filing means
DATA COLLECTIVE IV GP, LLC filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $67.98M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$67.98M
Total AUM (reported)
11.05M
Total Shares
Allocation by class
COM CL A$37.75M55.5%
CL A$28.99M42.6%
COM NEW$1.18M1.7%
SHS$58.6K0.1%
Portfolio Concentration
Top 3$67.93M99.9%
4–10$58.6K0.1%
Top 3 weight
99.9%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 11.05M
Sole
Full voting authority
11.05M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole4
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings4
Rows:
Evolv Technologies Holdings, Inc.
SOLEShares5M
TypeSH
Market value$37.75M
55.53%
Sole
5M
Shared
0.00
None
0.00
Recursion Pharmaceuticals, Inc.
SOLEShares5.94M
TypeSH
Market value$28.99M
42.65%
Sole
5.94M
Shared
0.00
None
0.00
Mind Medicine (MindMed) Inc.
SOLEShares100.35K
TypeSH
Market value$1.18M
1.74%
Sole
100.35K
Shared
0.00
None
0.00
Roivant Sciences Ltd.
SOLEShares3.88K
TypeSH
Market value$58.6K
0.09%
Sole
3.88K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Evolv Technologies Holdings, Inc.SOLE | COM CL A | 5M | SH | $37.75M 55.53% | 5M | 0.00 | 0.00 |
Recursion Pharmaceuticals, Inc.SOLE | CL A | 5.94M | SH | $28.99M 42.65% | 5.94M | 0.00 | 0.00 |
Mind Medicine (MindMed) Inc.SOLE | COM NEW | 100.35K | SH | $1.18M 1.74% | 100.35K | 0.00 | 0.00 |
Roivant Sciences Ltd.SOLE | SHS | 3.88K | SH | $58.6K 0.09% | 3.88K | 0.00 | 0.00 |